Farmacy

Aug 1 2017

Barr Pharmaceutical #biotech

#barr pharma #Barr Pharmaceutical Barr Pharmaceuticals, Inc. is a holding company, whose principal subsidiaries, Barr Laboratories, Inc. and Duramed Pharmaceuticals, Inc. develop, manufacture and market generic and proprietary pharmaceuticals. The Company s product portfolio includes more than 100 generic and proprietary pharmaceutical products in core therapeutic categories including female healthcare (including oral contraceptive and hormone therapy products), oncology, cardiovascular, anti-infective and psychotherapeutic pharmaceuticals. The Company is listed on the New York Stock Exchange under the symbol BRL. With fiscal 2004 revenues of $1.3 billion, the Company currently manufactures and distributes more than 100 pharmaceutical products in core therapeutic categories including …